122 related articles for article (PubMed ID: 31110180)
1. LNK suppresses interferon signaling in melanoma.
Ding LW; Sun QY; Edwards JJ; Fernández LT; Ran XB; Zhou SQ; Scolyer RA; Wilmott JS; Thompson JF; Doan N; Said JW; Venkatachalam N; Xiao JF; Loh XY; Pein M; Xu L; Mullins DW; Yang H; Lin DC; Koeffler HP
Nat Commun; 2019 May; 10(1):2230. PubMed ID: 31110180
[TBL] [Abstract][Full Text] [Related]
2. LNK/SH2B3 regulates IL-7 receptor signaling in normal and malignant B-progenitors.
Cheng Y; Chikwava K; Wu C; Zhang H; Bhagat A; Pei D; Choi JK; Tong W
J Clin Invest; 2016 Apr; 126(4):1267-81. PubMed ID: 26974155
[TBL] [Abstract][Full Text] [Related]
3. LNK (SH2B3): paradoxical effects in ovarian cancer.
Ding LW; Sun QY; Lin DC; Chien W; Hattori N; Dong XM; Gery S; Garg M; Doan NB; Said JW; Xiao JF; Yang H; Liu LZ; Meng X; Huang RY; Tang K; Koeffler HP
Oncogene; 2015 Mar; 34(11):1463-74. PubMed ID: 24704825
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of RIG-I mediated by ITGB3/c-SRC/STAT3 signaling confers resistance to interferon-α-induced apoptosis in tumor-repopulating cells of melanoma.
Li Y; Song Y; Li P; Li M; Wang H; Xu T; Yu X; Yu Y; Tai Y; Chen P; Cai X; Wang X; Xiang L; Deng R; Zhang X; Gao L; Wang X; Liu J; Cao F
J Immunother Cancer; 2020 Mar; 8(1):. PubMed ID: 32152220
[TBL] [Abstract][Full Text] [Related]
5. Lnk adaptor suppresses radiation resistance and radiation-induced B-cell malignancies by inhibiting IL-11 signaling.
Louria-Hayon I; Frelin C; Ruston J; Gish G; Jin J; Kofler MM; Lambert JP; Adissu HA; Milyavsky M; Herrington R; Minden MD; Dick JE; Gingras AC; Iscove NN; Pawson T
Proc Natl Acad Sci U S A; 2013 Dec; 110(51):20599-604. PubMed ID: 24297922
[TBL] [Abstract][Full Text] [Related]
6. Gene transfer of the adaptor Lnk (SH2B3) prevents porcine endothelial cell activation and apoptosis: implication for xenograft's cytoprotection.
Chatelais M; Devallière J; Galli C; Charreau B
Xenotransplantation; 2011; 18(2):108-20. PubMed ID: 21496118
[TBL] [Abstract][Full Text] [Related]
7. The adaptor Lnk (SH2B3): an emerging regulator in vascular cells and a link between immune and inflammatory signaling.
Devallière J; Charreau B
Biochem Pharmacol; 2011 Nov; 82(10):1391-402. PubMed ID: 21723852
[TBL] [Abstract][Full Text] [Related]
8. Lnk/Sh2b3 controls the production and function of dendritic cells and regulates the induction of IFN-γ-producing T cells.
Mori T; Iwasaki Y; Seki Y; Iseki M; Katayama H; Yamamoto K; Takatsu K; Takaki S
J Immunol; 2014 Aug; 193(4):1728-36. PubMed ID: 25024389
[TBL] [Abstract][Full Text] [Related]
9. Octa-arginine mediated delivery of wild-type Lnk protein inhibits TPO-induced M-MOK megakaryoblastic leukemic cell growth by promoting apoptosis.
Looi CY; Imanishi M; Takaki S; Sato M; Chiba N; Sasahara Y; Futaki S; Tsuchiya S; Kumaki S
PLoS One; 2011; 6(8):e23640. PubMed ID: 21853157
[TBL] [Abstract][Full Text] [Related]
10. Adaptor protein LNK is a negative regulator of brain neural stem cell proliferation after stroke.
Ahlenius H; Devaraju K; Monni E; Oki K; Wattananit S; Darsalia V; Iosif RE; Torper O; Wood JC; Braun S; Jagemann L; Nuber UA; Englund E; Jacobsen SE; Lindvall O; Kokaia Z
J Neurosci; 2012 Apr; 32(15):5151-64. PubMed ID: 22496561
[TBL] [Abstract][Full Text] [Related]
11. LNK/SH2B3 Loss of Function Promotes Atherosclerosis and Thrombosis.
Wang W; Tang Y; Wang Y; Tascau L; Balcerek J; Tong W; Levine RL; Welch C; Tall AR; Wang N
Circ Res; 2016 Sep; 119(6):e91-e103. PubMed ID: 27430239
[TBL] [Abstract][Full Text] [Related]
12. Lnk inhibits Tpo-mpl signaling and Tpo-mediated megakaryocytopoiesis.
Tong W; Lodish HF
J Exp Med; 2004 Sep; 200(5):569-80. PubMed ID: 15337790
[TBL] [Abstract][Full Text] [Related]
13. Expression of the adaptor protein Lnk in leukemia cells.
Gery S; Gueller S; Nowak V; Sohn J; Hofmann WK; Koeffler HP
Exp Hematol; 2009 May; 37(5):585-592.e2. PubMed ID: 19375649
[TBL] [Abstract][Full Text] [Related]
14. The antitumor effects of interferon-alpha are maintained in mice challenged with a STAT1-deficient murine melanoma cell line.
Badgwell B; Lesinski GB; Magro C; Abood G; Skaf A; Carson W
J Surg Res; 2004 Jan; 116(1):129-36. PubMed ID: 14732359
[TBL] [Abstract][Full Text] [Related]
15. Linking inflammation and hypertension via LNK/SH2B3.
Dale BL; Madhur MS
Curr Opin Nephrol Hypertens; 2016 Mar; 25(2):87-93. PubMed ID: 26717315
[TBL] [Abstract][Full Text] [Related]
16. The Lnk adaptor protein: a key regulator of normal and pathological hematopoiesis.
Velazquez L
Arch Immunol Ther Exp (Warsz); 2012 Dec; 60(6):415-29. PubMed ID: 22990499
[TBL] [Abstract][Full Text] [Related]
17. Melanoma cells exhibit variable signal transducer and activator of transcription 1 phosphorylation and a reduced response to IFN-alpha compared with immune effector cells.
Lesinski GB; Trefry J; Brasdovich M; Kondadasula SV; Sackey K; Zimmerer JM; Chaudhury AR; Yu L; Zhang X; Crespin TR; Walker MJ; Carson WE
Clin Cancer Res; 2007 Sep; 13(17):5010-9. PubMed ID: 17785551
[TBL] [Abstract][Full Text] [Related]
18. Impaired lymphopoiesis and altered B cell subpopulations in mice overexpressing Lnk adaptor protein.
Takaki S; Tezuka Y; Sauer K; Kubo C; Kwon SM; Armstead E; Nakao K; Katsuki M; Perlmutter RM; Takatsu K
J Immunol; 2003 Jan; 170(2):703-10. PubMed ID: 12517931
[TBL] [Abstract][Full Text] [Related]
19. KLF4 is regulated by RAS/RAF/MEK/ERK signaling through E2F1 and promotes melanoma cell growth.
Riverso M; Montagnani V; Stecca B
Oncogene; 2017 Jun; 36(23):3322-3333. PubMed ID: 28068326
[TBL] [Abstract][Full Text] [Related]
20. Role of the adaptor protein LNK in normal and malignant hematopoiesis.
Gery S; Koeffler HP
Oncogene; 2013 Jun; 32(26):3111-8. PubMed ID: 23045270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
